Moderna/Pfizer’s C19-V clinical trials involving children identified elevated rate of Respiratory Syncytial Virus (RSV). FDA's vaccine committee even voiced concerns. RSV now spiking in children. CDC's befuddling advice on RSV is to recommend more C19-V. https://t.co/RSwj1W89jK

— Aaron Siri (@AaronSiriSG) November 7, 2022